-
Recent Posts
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink / BGS)
- Timeless Good Advice? (Action for Happiness)
- The Diversionary Value of Music Playlists for Patients With Dementia in Accident and Emergency Settings (Nurses.co.uk / BBC News)
- More on the Possible Role of Neuroinflammation in Frontotemporal Dementia (Bazian / Brain)
Archives
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Pravastatin
Statins for the Treatment of Vascular Dementia or Alzheimer’s Disease (Cochrane Database)
Summary This Cochrane systematic review assesses the clinical efficacy and safety of statins for the treatment of Alzheimer’s Disease and vascular dementia. No studies exist yet assessing role of statins in treatment of vascular dementia. Analysis of four studies concerning … Continue reading
Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Pharmacological Treatments, Quick Insights
Tagged ADAS-Cog: Alzheimer’s Disease Assessment Scale - Cognitive Subscale, ALOIS: the Cochrane Dementia and Cognitive Improvement Group, Alzheimer’s Disease Cooperative Study - Activities of Daily Living (ADCS-ADL), Alzheimer’s Disease Functional Assessment and Change Scale (ADFACS), Atorvastatin, Belfast Health and Social Care Trust, Centre for Public Health: Queen's University Belfast, Cholesterol Reduction, Clinical Global Impression of Change (CGIC), Cochrane Database, Cochrane Dementia and Cognitive Improvement Group (CDCIG), Craigavon Area Hospital, Department of Geriatric Medicine: Belfast Health and Social Care Trust, Fluvastatin, Hypercholesterolaemia, Kingshill Research Centre: Victoria Hospital (Swindon), Lovastatin, Mini Mental State Examination (MMSE), Neuropsychiatric Inventory (NPI), Pravastatin, Queen's University Belfast, Rosuvastatin, Simvastatin, Statin Therapy, Statins, Statins for the Treatment of Alzheimer’s Disease, Statins for the Treatment of Vascular Dementia, University of Oxford, Use of Statins, VaD: Vascular Dementia, Vascular Dementia
Leave a comment
Statins: Effective, Affordable and Acceptable Risk-Benefit Profile (BBC News / NICE / BMJ / BMC Medicine)
Summary According to latest guidelines from the National Institute for Health and Care Excellence (NICE), four out of ten adults in England, Wales and Northern Ireland will be eligible for statins; even though they are at relatively low risk of … Continue reading
Posted in Acute Hospitals, BBC News, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, National, NHS, NICE Guidelines, Northern Ireland, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, Scotland, Standards, Statistics, Stroke, Systematic Reviews, UK, Universal Interest, Wales
Tagged Adherence to Statin Therapy, Adverse Effects, Alcohol Consumption, Atorvastatin, BBC Health News, BMC Medicine, BMJ, British Medical Association's General Practitioner Committee, British Medical Journal (BMJ), Cancer, Cardioprotective Diet, Cardiovascular Disease, Cardiovascular Risk, Cataracts, Cholesterol, Cholesterol Levels, Cholesterol-Lowering Drugs, Cholesterol-Lowering Medications, Chronic Obstructive Pulmonary Disease, Cognition, Cognitive Decline, Cognitive Impairment, Combined Interventions (Diet and Physical Activity), Concerns Over Statins Use, COPD, Costs of Statins (Declining), County Hospital (Hereford), CVD Risk Assessment, CVD: Cardiovascular Disease, Department of Geriatric Medicine: County Hospital (Hereford), Diabetes, Drug Side-Effects, Erectile Dysfunction, Evidence-Based Medicine, Eyes and Vision, Fatigue, Fluvastatin, Grouping of Statins (Three Intensity Categories), Harvard Medical School, Healthy Lifestyles, Hepatotoxicity, Informed Choice, Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, JUPITER Study, Kidney Disorders, Lifestyle Modifications for Primary and Secondary Prevention of CVD, Lifestyle Risk Factors, Lifestyle Weight Management, Lipid Lowering and Onset of Renal Disease (LORD) Study, Lipid Modification, Lipophilic Statins, Liver Disorders, Liver Toxicity, London School of Hygiene and Tropical Medicine, Low Density Lipoprotein Cholesterol (LDL-C), Mass Prescription, MCI: Mild Cognitive Impairment, Memory Lapses, Memory Loss, Memory Problems, Mild Cognitive Impairment (MCI), Misinformation About Statins (Historical), Modifiable Risk Factors, Muscle Toxicity, Musculo-Skeletal Disorders, Myopathy, National Institute for Health and Care Excellence (NICE), Neurological Disorders, Neuronal Cell Membranes, NHS Choices Health A-Z Information on Statins, NHS Choices: Healthy Cooking, NHS Choices: Healthy Diet, NHS Choices: Healthy Eating, NHS Choices: Physical Activity, NHS Health Checks Programme, NICE Clinical Guideline CG181, NICE Clinical Guideline CG67, Non-Cardiovascular Effects Associated With Statins, Non-Cardiovascular Harms of Statins, Non-Cardiovascular Side-Effects of Statins, Off-Label Use, Over-Medicalisation (Speculative Concept), Overdiagnosis (Speculative Concept), Overtreatment (Speculative Concept), Pancreatitis, Patient Choice, Patient-Doctor Discussion, Physical Activity, Physical Activity Prescriptions, Physical Activity Programmes, Potential Harms Associated With Statins, Pravastatin, Preventative Mass Prescription, Prospective Study of Pravastatin in the Elderly (PROSPER) Trial, QRISK2 Assessment Tool, QRISK2 Calculator, Renal Disorders, Respiratory Disorders, Rhabdomyolysis, Risk Factors, Risk Factors of Stroke, Rosuvastatin, Scandinavian Simvastatin Survival Study, Simvastatin, Smoking Cessation, Smoking Cessation Services, Statin Induced Myopathy, Statins, Statins for Stroke Prevention in Older Patients, Statins: Contraindicated in Pregnancy, Statins: Few Contraindications, Statins: Risk-Benefit Profile, Stroke Prevention in Older Patients, Stroke Risk Factor Modification, Unintended Effects of Statins, Urological Disorders, Use of Drugs Outside Their Licensed Indications, Use of Statins, Venous Thromboembolism, Weight Management
Leave a comment
Exposure to Statins in Early Old Age May Lower Risk of Alzheimer’s Disease
[This abstract first appeared in: Dementia: the Latest Evidence Newsletter RWHT Volume 1 Issue 7 February 2011]. Abstract This US prospective cohort study looked into whether statins (simvastatin, lovastatin, pravastatin and atorvastatin) reduce the risk of Alzheimer’s Disease (AD), and investigated the influence … Continue reading
